Cleared Traditional

K122381 - NEXFIN MODEL 2

K122381 is an FDA 510(k) clearance for NEXFIN MODEL 2, manufactured by Edwards Lifesciences, LLC. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 259-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2013
Decision
259d
Days
Class 2
Risk

K122381 is an FDA 510(k) clearance for the NEXFIN MODEL 2. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on April 22, 2013 after a review of 259 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Edwards Lifesciences, LLC devices

FDA 510(k) Submission Details - K122381

510(k) Number K122381 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 2012
Decision Date April 22, 2013
Days to Decision 259 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
134d slower than avg
Panel avg: 125d · This submission: 259d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 990
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K122381.
WRIST AUTOMATIC BLOOD PRESSURE MONITOR
K123800 · Little Doctor Electronic (Nantong)Co.,Ltd · May 2013
MICROLIFE UPPER ARM AUTOMATIC DIGITAL BLOOD PRESSURE MONITOR, CARDIO+ (BP4GAPO-2M)
K122013 · Microlife Corp. · May 2013
DIGITAL BLOOD PRESSURE MONITOR
K123600 · Little Doctor Electronic (Nantong)Co.,Ltd · May 2013
STAYHEALTHY HEALTH KIOSK, STAYHEALTHY HEALTHCENTER KIOSK
K123539 · Stayhealthy, Inc. · Apr 2013
PERSONAL HEALTH CENTER (PHC)
K122076 · Adflow Health Networks, Inc. · Apr 2013
APPS-HEALTH01
K122098 · Andon Health Co, Ltd. · Mar 2013